Cancer: Sarif Biomedical sues Accuray over CyberKnife

February 8, 2013 by MassDevice staff

Sarif Biomedical sues medical device company Accuray for patent infringement over the latter's CyberKnife cancer treatment device.


Sarif Biomedical accused Accuray (NSDQ:ARAY) of infringing 1 of its patents with the CyberKnife radiosurgery device for cancer, which uses targeted radiation blasts to destroy tumor cells.

Tool, Texas-based Sarif's patent covers ""Computer-Assisted Microsurgery Methods and Equipment." The medical device company alleges that Accuray's device trespasses on that intellectual property, according to the lawsuit.

The lawsuit, filed Jan. 28 in the U.S. District Court for Delaware, seeks a judgment of infringement and an injunction barring further infringement, damages, "[a] finding that this is an exceptional case," pre- and post-judgment interest and legal costs.

Sign up to get our free newsletters delivered straight to your inbox

"At this time, we do not have enough information to estimate what, if any, financial impact this claim will have," Accuray said this week in a regulatory filing.